ICF-based Comparison on Musculoskeletal Health in Poland and Spain
Launched by UNIVERSITY OF RZESZOW · Feb 21, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how musculoskeletal diseases, which affect bones, muscles, and joints, impact people's lives differently in Poland and Spain. Researchers want to learn more about these conditions and how they are experienced in different cultural settings. By using a standardized framework called the International Classification of Functioning, Disability and Health (ICF), the study aims to identify key differences that can help improve care for patients.
To participate in this study, individuals need to be between 18 and 65 years old and have a diagnosed musculoskeletal disorder. It's important that they can understand and communicate in either Polish or Spanish and have a good mental state to ensure accurate participation. Those with other mental health issues or unrelated health problems will not be eligible. Participants will share their experiences and perspectives on living with their condition, which will contribute to a better understanding of musculoskeletal health across different populations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age between 18 and 65 years,
- • diagnosed musculoskeletal disorder according to ICD-10,
- • normal cognitive status to perform reliable study (The Abbreviated Mental Test Score \>6),
- • informed and voluntary consent to participate in the study,
- • sufficient knowledge of the Spanish or Polish language.
- Exclusion Criteria:
- • mental disorders - depression or personality disorders confirmed by a medical diagnosis,
- • referral for a non-musculoskeletal problem,
- • referral from hospital services.
About University Of Rzeszow
The University of Rzeszow is a leading academic institution dedicated to advancing research and education in the health sciences. With a robust commitment to clinical research, the university actively sponsors innovative clinical trials aimed at enhancing medical knowledge and improving patient outcomes. Leveraging a multidisciplinary approach, the university collaborates with healthcare professionals, researchers, and industry partners to investigate novel therapies and interventions. Through its state-of-the-art facilities and expertise, the University of Rzeszow strives to contribute significantly to the development of evidence-based practices in medicine, fostering a healthier future for communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rzeszów, , Poland
Patients applied
Trial Officials
Agnieszka Wiśniowska-Szurlej, PhD
Principal Investigator
University of Rzeszow
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported